Cargando…

Risk of Hidradenitis Suppurativa Comorbidities Over Time: A Prospective Cohort Study of Danish Blood Donors

Hidradenitis suppurativa is a common recurrent inflammatory skin disease. It is associated with multiple comorbidities whose temporal relationships are unknown due to long diagnostic delays. This study of otherwise healthy blood donors with self-reported symptoms of hidradenitis suppurativa investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	ANDERSEN, Rune Kjærsgaard, LOFT, Isabella Charlotte, BURGDORF, Kristoffer, ERIKSTRUP, Christian, PEDERSEN, Ole B., JEMEC, Gregor B. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2021
Materias:	Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309826/ https://www.ncbi.nlm.nih.gov/pubmed/33372684 http://dx.doi.org/10.2340/00015555-3737

Ejemplares similares

Keratitis-ichthyosis-deafness syndrome and hidradenitis suppurativa
por: Travis, Lisa, et al.
Publicado: (2023)

Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
por: BOTVID, Sofia H. C., et al.
Publicado: (2023)

Epidemiology of Hyperhidrosis in Danish Blood Donors
por: HENNING, Mattias A. S., et al.
Publicado: (2021)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Quality of Life in Danish Blood Donors Treated for Superficial Fungal Infections
por: LINDSØ ANDERSEN, Pernille, et al.
Publicado: (2021)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

The association between water hardness and xerosis—Results from the Danish Blood Donor Study
por: Henning, Mattias A. S., et al.
Publicado: (2021)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Hidradenitis suppurativa prevalence in Berekum, Ghana: A cross-sectional study and initial validation of a questionnaire in an African setting
por: Hagan, Paa Gyasi, et al.
Publicado: (2020)

The differentiating effect of COVID-19-associated stress on the morbidity of blood donors with symptoms of hidradenitis suppurativa, hyperhidrosis, or psoriasis
por: Henning, M. A. S., et al.
Publicado: (2023)

Skin and Gut Microbiome in Hidradenitis Suppurativa: A Systematic Review
por: Lelonek, Edyta, et al.
Publicado: (2023)

Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease
por: Dufour, Deirdre Nathalie, et al.
Publicado: (2014)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Hidradenitis suppurativa: A review of post-operative outcomes
por: Elliott, J., et al.
Publicado: (2020)

Validation of the Hidradenitis Suppurativa Investigator Global Assessment: A Novel Hidradenitis Suppurativa–Specific Investigator Global Assessment for Use in Interventional Trials
por: Garg, Amit, et al.
Publicado: (2023)

Body Image Quality of Life in Patients with Hidradenitis Suppurativa Compared with Other Dermatological Disorders
por: LINDSØ ANDERSEN, Pernille, et al.
Publicado: (2020)

Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities
por: Lim, Ziying Vanessa, et al.
Publicado: (2016)

Comorbidities of hidradenitis suppurativa: A review of the literature
por: Cartron, Alexander, et al.
Publicado: (2019)

Socio-demographic characteristics of Danish blood donors
por: Burgdorf, Kristoffer Sølvsten, et al.
Publicado: (2017)

Effect of Hidradenitis Suppurativa Disease Duration on Psychiatric Comorbidity
por: TIRI, Hannu, et al.
Publicado: (2020)

Hidradenitis Suppurativa Quality of Life (HiSQOL): creation and validation of the Polish language version
por: Krajewski, Piotr K., et al.
Publicado: (2020)

Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes
por: Thorlacius, Linnea, et al.
Publicado: (2017)

Cytokine Autoantibodies Are Associated with Infection Risk and Self-Perceived Health: Results from the Danish Blood Donor Study
por: von Stemann, Jakob H., et al.
Publicado: (2020)

Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice
por: Tzellos, Thrasyvoulos, et al.
Publicado: (2020)

Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population
por: Kirsten, Natalia, et al.
Publicado: (2020)

Metabolic and Endocrine Comorbidities in Hidradenitis Suppurativa: A Nationwide Study
por: Edigin, Ehizogie, et al.
Publicado: (2021)

Low-Grade Inflammation Is Associated with Susceptibility to Infection in Healthy Men: Results from the Danish Blood Donor Study (DBDS)
por: Kaspersen, Kathrine Agergård, et al.
Publicado: (2016)

Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data
por: Daoud, Mathieu, et al.
Publicado: (2023)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

The Comorbidity Burden of Hidradenitis Suppurativa in the United States: A Claims Data Analysis
por: Kimball, Alexandra B., et al.
Publicado: (2018)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

Characterization of comorbidity heterogeneity among 13,667 patients with hidradenitis suppurativa
por: Hua, Vivian J., et al.
Publicado: (2021)

Hidradenitis suppurativa; classification, remedies, etiology, and comorbidities; a narrative review
por: Mohammadi, Sadaf, et al.
Publicado: (2021)

Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study
por: Calao, Miriam, et al.
Publicado: (2018)

Hidradenitis Suppurativa is Associated with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study
por: GONZÁLEZ-VILLANUEVA, Iris, et al.
Publicado: (2020)

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled portion of a phase 2 adalimumab study
por: Kimball, A.B., et al.
Publicado: (2015)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Hidradenitis Suppurativa: Inside and Out
por: Patil, Sharmila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_thm1kpcgnvlb2pqnl9g2cd7obf